Vetrepharm ApS: Financial statements 2014
CVR: 15206802
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
Vetrepharm ApS (CVR 15206802) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 1,073,164 and a net result of DKK 510,025 compared with DKK 465,793 the year before. That is an increase of 0.3% compared with the year before. Equity in the 2014 report amounted to DKK 1,403,320. The solvency ratio was 62.8%.
- Gross Profit
- DKK 1,073,164
- Profit/Loss
- DKK 510,025
- Equity
- DKK 1,403,320
- Total Assets
- DKK 2,234,877
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 1.1 mio. | 510 t. | 1.4 mio. | - |
| 2013 | - | 1.1 mio. | 466 t. | 1.4 mio. | - |
| 2012 | - | 1 mio. | 289 t. | 1.4 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
Vetrepharm ApS has published its annual report for 2013. Gross profit came to DKK 1,070,317, and the net result was DKK 465,793.
About Vetrepharm ApS
Vetrepharm ApS was a Danish company of the type Anpartsselskab based in Brande, founded in 1991. The company has been dissolved on 4 October 2021. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named VETREPHARM A/S and A/S PSE NR. 4365. The company has 1 employee (2020). In 2019, the company reported a gross profit of DKK -39,654 and a net result of DKK -84,121 compared with DKK -199,932 the year before. Equity in the 2019 report amounted to DKK -14,643.